Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study

K. Hoffken, F. Overkamp, J. Stirbu, A. Grothey, M. Flasshove, D. Hoelzer, A. Ganser

Research output: Contribution to journalArticle

13 Scopus citations
Original languageEnglish (US)
Pages (from-to)33-37
Number of pages5
JournalOnkologie
Volume13
Issue number1
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this